Omada Health
OMDA
20.89
+0.16
+0.77%
Omada Health
US · OMDA
#3099 by market cap
Listed 2025
20.89
+0.16
+0.77%
Live - 5344 symbols - heartbeat 166s ago
· 2026-10-08 07:32
Pre-market
20.81
-0.38%
After-hours
20.98
+0.43%
Overnight
20.69
-0.96%
- Market cap
- 1.28B
- P/E (TTM)i
- 294.23
- P/Bi
- 5.06
- EPSi
- -0.22
- Div yieldi
- 0.00%
- 52W posi
- 64%
Reader sentiment
Are you bullish or bearish on OMDA?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 11 analysts
Buy
Avg price target
28.27 +35.3%
Price target rangecurrent 20.89
Low22.00
Avg28.27
High35.00
Buy 91%
Hold 9%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-28 | Morgan Stanley | -- | BUY | 30.00 |
| 2026-09-14 | Wells Fargo | -- | HOLD | 22.00 |
| 2026-09-14 | Freedom Capital Markets | -- | BUY | 35.00 |
| 2026-09-11 | CCORF | -- | BUY | 28.00 |
| 2026-09-11 | BTIG | -- | BUY | 35.00 |
| 2026-09-11 | Evercore | -- | BUY | 25.00 |
| 2026-09-11 | Needham | -- | BUY | 28.00 |
| 2026-09-11 | BMO Capital | -- | BUY | 24.00 |
| 2026-09-11 | Barclays | -- | BUY | 27.00 |
| 2026-08-31 | Morgan Stanley | -- | BUY | 30.00 |
| 2026-08-14 | J.P. Morgan | -- | BUY | 30.00 |
| 2026-08-11 | CCORF | -- | BUY | 28.00 |
| 2026-08-10 | BTIG | -- | BUY | 35.00 |
| 2026-08-07 | CCORF | -- | BUY | 28.00 |
| 2026-08-07 | Morgan Stanley | -- | BUY | 30.00 |
| 2026-08-07 | Evercore | -- | BUY | 25.00 |
| 2026-08-07 | Needham | -- | BUY | 28.00 |
| 2026-08-07 | Barclays | -- | BUY | 25.00 |
| 2026-08-06 | BMO Capital | -- | BUY | 24.00 |
| 2026-08-03 | Morgan Stanley | -- | BUY | 30.00 |
| 2026-08-03 | Barclays | -- | BUY | 25.00 |
| 2026-07-20 | CCORF | -- | BUY | 28.00 |
| 2026-07-20 | Citizens JMP | -- | BUY | 27.00 |
| 2026-07-17 | BTIG | -- | BUY | 30.00 |
| 2026-07-14 | Morgan Stanley | -- | BUY | 30.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | After close | ±14.49% | +21.14% (beat) |
| 2026/Q1 | 2026-05-07 | After close | ±12.04% | -9.63% (in line) |
| 2025/Q4 | 2026-03-05 | After close | ±13.49% | +3.31% (in line) |
| 2025/Q3 | 2025-11-06 | After close | ±26.09% | -7.13% (in line) |
| 2025/Q2 | 2025-08-07 | After close | -- | -2.26% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:32:07 · For reference only, not investment advice and not tailored to your situation.